---
title: pathology of hodgkin lymphoma (HL)
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[hodgkin lymphoma (HL)]]

# pathology of hodgkin lymphoma (HL)
2 major types:
[[Classical HL]], [[Nodular lymphocyte-predominant Hodgkin lymphoma|NLPHL]]
> (Blood 2010; 116: 3268, Blood 2015; 125:1061)

* Affected nodes show RS cells (<1%) in background of **non-neoplastic inflammatory** cells

## Classic RS cells:
* **bilobed** nucleus
* & prominent nucleoli with surrounding clear space (â€œowlâ€™s eyesâ€).
* RS cells are **clonal B-cells**:
	1. CD15+
	2. CD30+
	3. CD20â€“ (rarely +).

## å¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤ï¼ˆClassical HLï¼‰å’Œéžæ·‹å·´çµ„ç¹”ç´°èƒžæ€§éœå¥‡é‡‘æ·‹å·´ç˜¤ï¼ˆNLPHLï¼‰æ˜¯å…©ç¨®ä¸»è¦é¡žåž‹ï¼š
- æ‘˜è¦ï¼šå¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤ï¼ˆClassical HLï¼‰å’Œéžæ·‹å·´çµ„ç¹”ç´°èƒžæ€§éœå¥‡é‡‘æ·‹å·´ç˜¤ï¼ˆNLPHLï¼‰æ˜¯å…©ç¨®ä¸»è¦é¡žåž‹ã€‚
- åŽŸæ–‡ï¼š2 major types: Classical HL, NLPHL
- é—œéµå­—ï¼š#å¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤, #éžæ·‹å·´çµ„ç¹”ç´°èƒžæ€§éœå¥‡é‡‘æ·‹å·´ç˜¤

## å¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤çš„ç—…ç†ç‰¹å¾µï¼š
- æ‘˜è¦ï¼šå¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤çš„ç—…ç†ç‰¹å¾µæ˜¯Reed-Sternbergç´°èƒžï¼šå¤§åž‹ã€å¤šæ ¸ç´°èƒžï¼Œå…·æœ‰ç¶“å…¸çš„â€œè²“é ­é·¹çœ¼â€å¤–è§€ï¼Œä¸”CD15å’ŒCD30å‘ˆé™½æ€§æŸ“è‰²ã€‚
- åŽŸæ–‡ï¼šClassical HL characterized pathologically by the Reedâ€“Sternberg Cell: large, multinucleated cell w/ classic â€œowlâ€™s eyesâ€ appearance & stains (+) for CD15 & CD30
- é—œéµå­—ï¼š#Reed-Sternbergç´°èƒž, #CD15, #CD30

## å¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤çš„äºžåž‹ï¼š
- æ‘˜è¦ï¼šå¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤çš„äºžåž‹åŒ…æ‹¬ï¼š
	- çµç¯€æ€§ç¡¬åŒ–åž‹ï¼ˆæœ€å¸¸è¦‹ï¼‰
	- å¯Œæ·‹å·´ç´°èƒžåž‹
	- æ··åˆç´°èƒžåž‹å’Œæ·‹å·´ç´°èƒžæ¶ˆè€—åž‹
		- é€™äº›äºžåž‹ä¹‹é–“çš„æ²»ç™‚ä¸¦ç„¡ä¸åŒ
- åŽŸæ–‡ï¼šSubtypes of Classical HL include: Nodular sclerosis (most common), lymphocyte rich, mixed cellularity, & lymphocyte depleted. Tx does not differ among these subtypes
- é—œéµå­—ï¼š#çµç¯€æ€§ç¡¬åŒ–åž‹, #å¯Œæ·‹å·´ç´°èƒžåž‹, #æ··åˆç´°èƒžåž‹, #æ·‹å·´ç´°èƒžæ¶ˆè€—åž‹

## å¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤ä¸­æœ€å¸¸è¦‹çš„åŸºå› æ”¹è®Šï¼š
- æ‘˜è¦ï¼šå¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤ä¸­æœ€å¸¸è¦‹çš„åŸºå› æ”¹è®Šæ˜¯
	- 9p24.1çš„æ‰©å¢žï¼Œ
	- å…¶ä¸­åŒ…å«PD-L1ã€PD-L2å’ŒJAK2åŸºå› ï¼Œ
	- ä»¥åŠÎ²-2å¾®çƒè›‹ç™½åŸºå› çš„çªè®Šï¼Œå¯¼è‡´å…ç–«é€ƒé€¸ã€‚
- åŽŸæ–‡ï¼šThe most common genetic alterations in cHL are amplification of 9p 24.1 containing the PD-L1, PD-L2, & JAK2 genes as well as Mts of the beta-2 microglobulin gene resulting in immune evasion (Blood 2010; 116: 3268, Blood 2015; 125:1061)
- é—œéµå­—ï¼š#å¤å…¸åž‹éœå¥‡é‡‘æ·‹å·´ç˜¤, #åŸºå› æ”¹è®Š, #9p24.1, #PD-L1, #PD-L2, #JAK2, #Î²-2å¾®çƒè›‹ç™½

## éžæ·‹å·´çµ„ç¹”ç´°èƒžæ€§éœå¥‡é‡‘æ·‹å·´ç˜¤çš„ç‰¹é»žï¼š
- æ‘˜è¦ï¼š
	- éžæ·‹å·´çµ„ç¹”ç´°èƒžæ€§éœå¥‡é‡‘æ·‹å·´ç˜¤æ˜¯ä¸€ç¨®é€²å±•ç·©æ…¢çš„ç–¾ç—…
	- å…¶ç‰¹å¾µæ˜¯æ·‹å·´ç´°èƒžå’Œçµ„ç¹”ç´°èƒž
	- é€™æ˜¯ä¸€ç¨®Reed-Sternbergè®Šç•°åž‹ç´°èƒž
	- CD15å’ŒCD30å‘ˆé™°æ€§æŸ“è‰²ï¼Œä½†**CD20**å‘ˆé™½æ€§æŸ“è‰²
- åŽŸæ–‡ï¼šNLPHL is a more indolent disease characterized by the Lymphocytic & Histiocytic cell, a Reedâ€“Sternberg variant that stains negative for CD15 & CD30, but (+) for CD20
- é—œéµå­—ï¼š#éžæ·‹å·´çµ„ç¹”ç´°èƒžæ€§éœå¥‡é‡‘æ·‹å·´ç˜¤, #æ·‹å·´ç´°èƒž, #çµ„ç¹”ç´°èƒž, #Reed-Sternbergè®Šç•°åž‹ç´°èƒž, #CD15, #CD30, #CD20
